Sidley’s Meena Datta Named an “Emerging Therapies/Life Sciences Trailblazer” by The National Law Journal

Meenakshi (Meena) Datta, a partner in Sidley’s office in Chicago, has been named to The National Law Journal’s list of “Emerging Therapies/Life Sciences Trailblazers.” The annual supplement celebrates the legal professionals who are true innovators in their field by assisting the most novel life sciences companies with their most challenging legal issues.

Meena is a member of Sidley’s Executive Committee, a leader within the firm’s Global Life Sciences Leadership Council, and co-leader of the firm’s Healthcare practice. As the counsel of choice for biotechnology companies developing cell and gene therapies, Meena’s experience includes obtaining a precedent-setting travel and lodging OIG advisory opinion to support patient access to these innovative therapies, and serving as outside counsel in connection with the launch of six of the nine cell and gene therapy products currently on the market. She is also a leading regulatory authority on digital therapeutics, an emerging and exciting life sciences product category that raises complex questions involving pricing, reimbursement, coding, and coverage.